Taxanes for Ovarian Cancer during Pregnancy: A Systematic Review
Authors:
- Flora ZagouriFZFlora Zagouri
- Theodoros N. SergentanisTSTheodoros N. Sergentanis
- Dimosthenis ChrysikosDCDimosthenis Chrysikos
- Martin FilipitsMFMartin Filipits
- Rupert BartschRBRupert Bartsch
- 1 August 2012
- journal article
- review article
- Published by S. Karger AG in Oncology
- Vol. 83 (4) , 234-238
Abstract
Objective: Ovarian cancer in pregnancy is uncommon; however, this diagnosis adds complexity to cancer treatment recommendations. This is the first systematic review to synthesize all available data and evaluate the efficacy and safety of taxanes during pregnancy in ovarian cancer. Methods: This systematic review was performed in accordance with PRISMA guidelines. All studies that examined the efficacy and safety of taxanes administered during pregnancy in ovarian cancer, regardless of sample size, were considered eligible. Results: Overall, 8 articles (11 pregnancies, 12 newborns) were retrieved for paclitaxel and 1 for docetaxel (1 pregnancy, 1 newborn). In 92.31% of cases a healthy child was born, with a median follow-up of 20 months. The mean weight of the babies at delivery was 2,381 g. One study providing follow-up until the 11th year of age reported a case of attention deficit disorder. In 6 out of 8 case reports providing survival data, the mother was alive and disease free at the end of follow-up (ranging from 9.75 to 45 months). Conclusion: Taxanes may play a significant role in the treatment of ovarian cancer patients during the 2nd and 3rd trimesters. Before that, the risk of abortion or congenital anomalies is increased.Keywords
This publication has 19 references indexed in Scilit:
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Achievements and unmet needs in the management of advanced ovarian cancerGynecologic Oncology, 2010
- Taxanes for breast cancer during pregnancy: a systematic reviewAnnals of Oncology, 2009
- Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During PregnancyJournal of Thoracic Oncology, 2009
- Emerging therapeutic options for breast cancer chemotherapy during pregnancyAnnals of Oncology, 2007
- Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case reportAmerican Journal of Obstetrics and Gynecology, 2007
- Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature reviewInternational Journal of Gynecological Cancer, 2007
- Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancerObstetrics & Gynecology, 2003
- Paclitaxel and Platinum Chemotherapy for Ovarian Carcinoma during PregnancyGynecologic Oncology, 2001